Orgenesis Profit Margin

The latest profit margin for ORGS is 191.53% as of September 2024. That compares with 10.78% in the prior-year period — up 1676.0% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Orgenesis's historical trend and sector peers before judging valuation or financial health.

Over the past year, ORGS's profit margin moved from 10.78% to 191.53% — a 1676.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orgenesis's valuation or profitability profile.

Against Healthcare companies, ORGS currently prints 191.53% for profit margin, while the sector average sits near 13.89%. That is roughly 1278.6% above the sector mean. Large gaps often invite a closer look at Orgenesis's growth, margins, and balance sheet.

Profit Margin shows how effectively Orgenesis converts resources into returns. At 191.53%, ORGS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 10.78% in the prior-year period — up 1676.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ORGS's profit margin (191.53%), review year-over-year change from 10.78%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.